• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lactose (India) Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Toshniwal
  • BSE Code : 2283.0
  • ISIN : INE058I01013
103.45 3 (2.63%)
  • As on 22 Sep 2026 (EOD)

  • Today’s Low

    98.55

  • Today’s High

    103.45

  • Open

    101.00

  • Perv Close

    100.80

  • 52W Low

    76.01

  • 52W High

    136.45

Key Indicators

  • P/E(TTM)

    18.81

  • Mar.Cap (₹Cr.)

    130.23

  • Div & Yield %

    0.00

  • Book Value(₹)

    46.28

  • Debt-Equity Ratio

    2.63

  • AGM Date

    22-Sep-2026

  • EPS

    5.50

  • P/E Ratio

    18.81

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    130.23

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.59

  • BV (₹)

    46.30

  • Sales( ₹ in Cr.)

    163.29

  • NP (in Cr.)

    6.06

  • NP Var(%)

    18.0

  • Div%

    0.0

  • CPS (₹)

    9.40

  • EPS (₹)

    4.80

  • Traded Value (₹ in Lakhs)

    130.23

  • 52 Week High

    136.45

  • 52 Week Low

    76.01

  • Price BSE

    103.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    130.23

  • P/C Ratio

    11.00

  • P/E Ratio

    21.40

  • Price Vs.BV

    4.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 163.29 116.40 113.89 65.80 45.94 34.96
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 163.29 116.40 113.89 65.80 45.94 34.96
Other Income 1.07 1.45 1.12 0.72 0.58 0.31
Stock Adjustments -6.77 8.14 -2.70 11.31 -0.40 -0.52
Total Income 157.59 125.99 112.31 77.83 46.12 34.75
EXPENDITURE :            
Raw Materials 87.52 60.51 48.86 35.50 7.18 4.65
Power and Fuel Cost 11.02 10.28 9.69 7.09 6.89 5.84
Employee Cost 12.17 10.50 8.72 6.57 12.25 10.63
Other Manufacturing Expenses 14.52 14.56 14.34 10.11 1.98 1.64
Selling and Administration Expenses 10.44 9.64 8.65 4.28 2.89 2.80
Miscellaneous Expenses 2.48 2.09 1.92 2.18 2.08 2.65
Employee Benefit Expenses 12.17 10.50 8.72 6.57 12.25 10.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 138.15 107.58 92.18 65.74 33.28 28.22
Operating Profit 19.45 18.41 20.13 12.10 12.85 6.54
Interest 5.09 6.10 5.25 5.95 5.12 5.45
Gross Profit 14.36 12.31 14.88 6.15 7.73 1.09
Depreciation 5.74 5.39 5.22 4.69 4.56 4.36
Profit Before Tax 8.62 6.92 9.66 1.46 3.17 -3.27
Current Tax 1.22 1.32 1.57 0.18 0.57 0.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.34 0.44 1.31 0.08 0.15 -0.84
Reported Net Profit 6.06 5.16 6.79 1.21 2.45 -2.48
Extraordinary Items 0.00 0.04 0.01 0.02 0.03 0.00
Adjusted Net Profit 6.06 5.12 6.78 1.19 2.42 -2.48
Adjustment below Net Profit -0.01 -0.05 -0.25 0.00 0.00 0.00
P & L Balance brought forward 25.79 20.67 14.14 12.84 10.39 12.87
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 31.84 25.79 20.67 14.05 12.84 10.39
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.82 4.10 5.39 0.96 1.95 -2.17
Earnings Per Share(Adj)-Unit Curr 4.82 4.10 5.39 0.96 1.95 -2.17
Book Value 46.28 41.48 37.41 32.22 31.21 30.15
Book Value(Adj)-Unit Curr 46.28 41.48 37.41 32.22 31.21 30.15

Shareholding Pattern

  • Promoter Group

    53.65%

  • Public Share Holding

    46.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,428,242 43.12 5,428,242 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 1,325,184 10.53 1,325,184 1
Others 0 0.00 0 0
Sub Total 6,753,426 53.65 6,753,426 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 77,920 0.62 0 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 77,920 0.62 0 4
2] Non Institution
Bodies Corporate 787,533 6.26 770,486 61
Clearing Members 260 0.00 260 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 38,318 0.30 38,318 62
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 105,389 0.84 105,389 93
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 685,759 5.45 685,759 18
Individuals holding nominal share capital up to Rs. 1 lakh 4,140,395 32.89 2,043,182 16,306
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,757,654 45.74 3,643,394 16,544
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,589,000 100.00 10,396,820 16,554

Company Background

Lactose (India) LtdPharmaceuticals - Indian - Bulk Drugs

  • Lactose (India) Ltd
  • BSE Code : 2283.0
  • ISIN : INE058I01013

  • Incorporation Year

    1991

  • Registered Office

    Survey No 6
    Village Poicha (Rania) Savli, Vadodara,
    Gujarat-391780

  • Telephone

    91-02667-244308/244729

  • FAX

    91-02667-840397

  • Chairman

    Atul Maheshwari

  • Managing Director

    Atul Maheshwari

  • Company Secretary

    Ritesh Pandey

  • Auditor

    CAS & Co/S G C O & CO LLP/DMKH & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Lactose (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77